Assay Development deals with the creation, optimization, and standardization of bioanalytical, serological and virological assays and tests associated with vaccines’ immunogenicity assessment and epidemiological screening.

The VisMederi Research  team guarantees proven experience in conducting a wide range of assays, including:

  • Serological assays for Influenza vaccines evaluation and licensing 
  • Neutralization assay for emerging pathogens (SARS-CoV-2, Yellow Fever, Dengue, West Nile, etc.)
  • Antigenic Drift of influenza vaccine stocks
  • Pseudoparticle development for Neutralization assays (PPN) (Rabied, Lassa, Influenza NA etc)
  • ELISA (Enzyme-Linked Immunosorbent Assay) assays for antigen and antibody detection
  • Immunofluorescence tests for detection of specific antibodies
  • Viral Growth in cell culture and hen’s eggs (Influenza)
  • Analysis of cell-mediated immune response using cytofluorometry (FACS) and ELISpot assay
  • Single Radial Diffusion Assay (SRD) for the quantification of viral antigens
  • Real Time RT-PCR